← All trials
NCT02349945
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2011
- Primary completion
- Dec 1, 2014
- Completion date
- Dec 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 88
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of Modena and Reggio EmiliaLead sponsor
- University of Modena and Reggio EmiliaOverall official - principal investigator
- University of PadovaCollaborator
- University of FlorenceCollaborator
- University of HalleCollaborator
- Istituto Clinico Humanitas - Rozzano (MI), ItalyCollaborator
- University of Modena and Reggio EmiliaReponsible party - principal investigator
- University of Roma La SapienzaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.